Luca Visini

Lilly India enters the autoimmune segment with Olumiant™, a new once-daily oral therapy for Rheumatoid Arthritis

Mumbai, November 11, 2018: Eli Lilly and Company (India) Pvt. Ltd. (“Lilly India”) announced the launch of Olumiant™ (baricitinib). This…

6 years ago

Eli Lilly and Company appoints Luca Visini Managing Director for its operations in India

Bengaluru, February 14, 2018: Multinational biopharmaceutical leader, Eli Lilly and Company, announce dearlier this year the appointment of Luca Visini as Managing…

7 years ago